{
  "success": true,
  "pagesUsed": [
    2,
    3,
    6,
    8,
    12,
    13,
    15,
    16,
    20,
    29
  ],
  "modelUsed": "gemini-3-flash-preview",
  "narrative": {
    "narrativeContents": [
      {
        "id": "nc_1",
        "name": "PROTOCOL SUMMARY",
        "text": "PROTOCOL SUMMARY",
        "order": 0,
        "instanceType": "NarrativeContent",
        "sectionNumber": "1",
        "sectionTitle": "PROTOCOL SUMMARY",
        "sectionType": {
          "id": "014e2bd8-14fd-4594-be06-1946a6fbba76",
          "code": "Synopsis",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Synopsis",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_1_1",
          "nci_1_2",
          "nci_1_3"
        ]
      },
      {
        "id": "nc_2",
        "name": "INTRODUCTION",
        "text": "INTRODUCTION",
        "order": 1,
        "instanceType": "NarrativeContent",
        "sectionNumber": "2",
        "sectionTitle": "INTRODUCTION",
        "sectionType": {
          "id": "45ed3d68-647f-4c77-8346-67b374af6df8",
          "code": "Introduction",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Introduction",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_2_1",
          "nci_2_2",
          "nci_2_3"
        ]
      },
      {
        "id": "nc_3",
        "name": "OBJECTIVES AND ENDPOINTS",
        "text": "OBJECTIVES AND ENDPOINTS",
        "order": 2,
        "instanceType": "NarrativeContent",
        "sectionNumber": "3",
        "sectionTitle": "OBJECTIVES AND ENDPOINTS",
        "sectionType": {
          "id": "6a44c6f5-cd1d-4b69-a521-4b5e8ffea157",
          "code": "Objectives",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Objectives",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_4",
        "name": "STUDY DESIGN",
        "text": "STUDY DESIGN",
        "order": 3,
        "instanceType": "NarrativeContent",
        "sectionNumber": "4",
        "sectionTitle": "STUDY DESIGN",
        "sectionType": {
          "id": "83410554-2330-438c-8601-7649d98783cb",
          "code": "Study Design",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Design",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_4_1",
          "nci_4_2",
          "nci_4_3",
          "nci_4_4",
          "nci_4_5"
        ]
      },
      {
        "id": "nc_5",
        "name": "STUDY POPULATION",
        "text": "STUDY POPULATION",
        "order": 4,
        "instanceType": "NarrativeContent",
        "sectionNumber": "5",
        "sectionTitle": "STUDY POPULATION",
        "sectionType": {
          "id": "0b4766d9-fcd1-4c96-863a-86f4473f7c88",
          "code": "Study Population",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Population",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_5_1",
          "nci_5_2",
          "nci_5_3",
          "nci_5_4"
        ]
      },
      {
        "id": "nc_6",
        "name": "STUDY INTERVENTION",
        "text": "STUDY INTERVENTION",
        "order": 5,
        "instanceType": "NarrativeContent",
        "sectionNumber": "6",
        "sectionTitle": "STUDY INTERVENTION",
        "sectionType": {
          "id": "bf0a27f8-c66d-4114-aa7b-83426236d631",
          "code": "Treatment",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_7",
        "name": "Study and Site Start and Closure",
        "text": "Study and Site Start and Closure",
        "order": 6,
        "instanceType": "NarrativeContent",
        "sectionNumber": "10.1.8",
        "sectionTitle": "Study and Site Start and Closure",
        "sectionType": {
          "id": "3208ccd7-1560-4f40-a06a-517584576fe2",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_8",
        "name": "Publication Policy",
        "text": "Publication Policy",
        "order": 7,
        "instanceType": "NarrativeContent",
        "sectionNumber": "10.1.9",
        "sectionTitle": "Publication Policy",
        "sectionType": {
          "id": "8e277eac-5dae-434e-99dc-7affb7180dae",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_9",
        "name": "Clinical Laboratory Tests",
        "text": "Clinical Laboratory Tests",
        "order": 8,
        "instanceType": "NarrativeContent",
        "sectionNumber": "10.2",
        "sectionTitle": "Clinical Laboratory Tests",
        "sectionType": {
          "id": "35445d9e-c2c0-4c20-ae90-05de8f6dbd5f",
          "code": "Assessments",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Assessments",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_10",
        "name": "Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting",
        "text": "Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting",
        "order": 9,
        "instanceType": "NarrativeContent",
        "sectionNumber": "10.3",
        "sectionTitle": "Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting",
        "sectionType": {
          "id": "214c08be-db6d-43d9-9b8b-2166dee169c6",
          "code": "Safety",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Safety",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_10_1",
          "nci_10_2",
          "nci_10_3",
          "nci_10_4"
        ]
      },
      {
        "id": "nc_11",
        "name": "Contraceptive Guidance and Collection of Pregnancy Information",
        "text": "Contraceptive Guidance and Collection of Pregnancy Information",
        "order": 10,
        "instanceType": "NarrativeContent",
        "sectionNumber": "10.4",
        "sectionTitle": "Contraceptive Guidance and Collection of Pregnancy Information",
        "sectionType": {
          "id": "14d813ae-5581-451b-af80-f886cfe8027b",
          "code": "Ethics",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Ethics",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_11_1",
          "nci_11_2"
        ]
      },
      {
        "id": "nc_12",
        "name": "COVID-19 Vaccine Risk Assessment",
        "text": "COVID-19 Vaccine Risk Assessment",
        "order": 11,
        "instanceType": "NarrativeContent",
        "sectionNumber": "10.5",
        "sectionTitle": "COVID-19 Vaccine Risk Assessment",
        "sectionType": {
          "id": "6996b08f-d7e2-438a-81f2-9ef82e17b286",
          "code": "Safety",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Safety",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_13",
        "name": "Abbreviations",
        "text": "Abbreviations",
        "order": 12,
        "instanceType": "NarrativeContent",
        "sectionNumber": "10.6",
        "sectionTitle": "Abbreviations",
        "sectionType": {
          "id": "935d3675-fbbb-4c0e-9369-1c4c16e5ef28",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_14",
        "name": "Protocol Amendment History",
        "text": "Protocol Amendment History",
        "order": 13,
        "instanceType": "NarrativeContent",
        "sectionNumber": "10.7",
        "sectionTitle": "Protocol Amendment History",
        "sectionType": {
          "id": "41126525-89e3-42a3-9414-2460c199433f",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_15",
        "name": "REFERENCES",
        "text": "REFERENCES",
        "order": 14,
        "instanceType": "NarrativeContent",
        "sectionNumber": "11",
        "sectionTitle": "REFERENCES",
        "sectionType": {
          "id": "4d9b1fc9-13ad-49c4-9c20-9fb6518e724e",
          "code": "References",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "References",
          "instanceType": "Code"
        }
      }
    ],
    "narrativeContentItems": [
      {
        "id": "nci_1_1",
        "name": "Synopsis",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.1",
        "sectionTitle": "Synopsis"
      },
      {
        "id": "nci_1_2",
        "name": "Schema",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.2",
        "sectionTitle": "Schema"
      },
      {
        "id": "nci_1_3",
        "name": "Schedule of Activities (SoA)",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.3",
        "sectionTitle": "Schedule of Activities (SoA)"
      },
      {
        "id": "nci_2_1",
        "name": "Study Rationale",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.1",
        "sectionTitle": "Study Rationale"
      },
      {
        "id": "nci_2_2",
        "name": "Background",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.2",
        "sectionTitle": "Background"
      },
      {
        "id": "nci_2_3",
        "name": "Benefit-Risk Assessment",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.3",
        "sectionTitle": "Benefit-Risk Assessment"
      },
      {
        "id": "nci_4_1",
        "name": "Overall Design",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.1",
        "sectionTitle": "Overall Design"
      },
      {
        "id": "nci_4_2",
        "name": "Scientific Rationale for Study Design",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.2",
        "sectionTitle": "Scientific Rationale for Study Design"
      },
      {
        "id": "nci_4_3",
        "name": "Participant Input into Design",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.2.1",
        "sectionTitle": "Participant Input into Design"
      },
      {
        "id": "nci_4_4",
        "name": "Justification for Dose",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.3",
        "sectionTitle": "Justification for Dose"
      },
      {
        "id": "nci_4_5",
        "name": "End of Study Definition",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.4",
        "sectionTitle": "End of Study Definition"
      },
      {
        "id": "nci_5_1",
        "name": "Inclusion Criteria",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.1",
        "sectionTitle": "Inclusion Criteria"
      },
      {
        "id": "nci_5_2",
        "name": "Exclusion Criteria",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.2",
        "sectionTitle": "Exclusion Criteria"
      },
      {
        "id": "nci_5_3",
        "name": "Lifestyle Considerations",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.3",
        "sectionTitle": "Lifestyle Considerations"
      },
      {
        "id": "nci_5_4",
        "name": "Screen Failures",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.4",
        "sectionTitle": "Screen Failures"
      },
      {
        "id": "nci_10_1",
        "name": "Definition of AE",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "10.3.1",
        "sectionTitle": "Definition of AE"
      },
      {
        "id": "nci_10_2",
        "name": "Definition of SAE",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "10.3.2",
        "sectionTitle": "Definition of SAE"
      },
      {
        "id": "nci_10_3",
        "name": "Recording and Follow-Up of AE and/or SAE",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "10.3.3",
        "sectionTitle": "Recording and Follow-Up of AE and/or SAE"
      },
      {
        "id": "nci_10_4",
        "name": "Reporting of SAEs",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "10.3.4",
        "sectionTitle": "Reporting of SAEs"
      },
      {
        "id": "nci_11_1",
        "name": "Definitions and Contraceptive Guidance",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "10.4.1",
        "sectionTitle": "Definitions and Contraceptive Guidance"
      },
      {
        "id": "nci_11_2",
        "name": "Collection of Pregnancy Information",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "10.4.2",
        "sectionTitle": "Collection of Pregnancy Information"
      }
    ],
    "abbreviations": [
      {
        "id": "abbr_1",
        "abbreviatedText": "ADME",
        "expandedText": "absorption, distribution, metabolism, and excretion",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_2",
        "abbreviatedText": "AE",
        "expandedText": "adverse event",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_3",
        "abbreviatedText": "ALT",
        "expandedText": "alanine aminotransferase",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_4",
        "abbreviatedText": "AP",
        "expandedText": "accumulation period",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_5",
        "abbreviatedText": "AST",
        "expandedText": "aspartate aminotransferase",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_6",
        "abbreviatedText": "BMI",
        "expandedText": "body mass index",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_7",
        "abbreviatedText": "C-I",
        "expandedText": "check-in",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_8",
        "abbreviatedText": "CRU",
        "expandedText": "clinical research unit",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_9",
        "abbreviatedText": "Cu",
        "expandedText": "copper",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_10",
        "abbreviatedText": "D",
        "expandedText": "day",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_11",
        "abbreviatedText": "ECG",
        "expandedText": "electrocardiogram",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_12",
        "abbreviatedText": "EOS",
        "expandedText": "End of Study",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_13",
        "abbreviatedText": "EOS/ET",
        "expandedText": "End of Study or Early Termination",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_14",
        "abbreviatedText": "FDA",
        "expandedText": "Food and Drug Administration",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_15",
        "abbreviatedText": "HIV",
        "expandedText": "human immunodeficiency virus",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_16",
        "abbreviatedText": "HR",
        "expandedText": "heart rate",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_17",
        "abbreviatedText": "I/O",
        "expandedText": "input/output",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_18",
        "abbreviatedText": "IB",
        "expandedText": "Investigator’s Brochure",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_19",
        "abbreviatedText": "IECs",
        "expandedText": "Independent Ethics Committees",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_20",
        "abbreviatedText": "IRBs",
        "expandedText": "Institutional Review Boards",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_21",
        "abbreviatedText": "LBC",
        "expandedText": "labile bound copper",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_22",
        "abbreviatedText": "Mo",
        "expandedText": "molybdenum",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_23",
        "abbreviatedText": "NCC",
        "expandedText": "non-ceruloplasmin-bound copper",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_24",
        "abbreviatedText": "NCCcorrected",
        "expandedText": "non-ceruloplasmin corrected copper concentrations corrected for TPC",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_25",
        "abbreviatedText": "OP",
        "expandedText": "outpatient",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_26",
        "abbreviatedText": "PD",
        "expandedText": "pharmacodynamic",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_27",
        "abbreviatedText": "PK",
        "expandedText": "pharmacokinetic",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_28",
        "abbreviatedText": "PUF",
        "expandedText": "plasma ultrafiltrate",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_29",
        "abbreviatedText": "PUF-Cu",
        "expandedText": "plasma ultrafiltrate copper",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_30",
        "abbreviatedText": "PUF-Mo",
        "expandedText": "plasma ultrafiltrate molybdenum",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_31",
        "abbreviatedText": "SAE",
        "expandedText": "serious adverse event",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_32",
        "abbreviatedText": "SoA",
        "expandedText": "Schedule of Activities",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_33",
        "abbreviatedText": "SS",
        "expandedText": "steady state",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_34",
        "abbreviatedText": "TPC",
        "expandedText": "tetrathiomolybdate- copper -albumin tripartite complex",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_35",
        "abbreviatedText": "UNS",
        "expandedText": "unscheduled",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_36",
        "abbreviatedText": "WD",
        "expandedText": "Wilson disease",
        "instanceType": "Abbreviation"
      }
    ],
    "summary": {
      "sectionCount": 15,
      "itemCount": 21,
      "abbreviationCount": 36
    },
    "studyDefinitionDocument": {
      "id": "sdd_1",
      "name": "A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
      "documentType": "Protocol",
      "language": "en",
      "instanceType": "StudyDefinitionDocument",
      "version": "3.1 (US)",
      "versionDate": "18 Mar 2022",
      "contentIds": [
        "nc_1",
        "nc_2",
        "nc_3",
        "nc_4",
        "nc_5",
        "nc_6",
        "nc_7",
        "nc_8",
        "nc_9",
        "nc_10",
        "nc_11",
        "nc_12",
        "nc_13",
        "nc_14",
        "nc_15"
      ]
    }
  },
  "rawResponse": {
    "abbreviations": {
      "abbreviations": [
        {
          "abbreviation": "ADME",
          "expansion": "absorption, distribution, metabolism, and excretion"
        },
        {
          "abbreviation": "AE",
          "expansion": "adverse event"
        },
        {
          "abbreviation": "ALT",
          "expansion": "alanine aminotransferase"
        },
        {
          "abbreviation": "AP",
          "expansion": "accumulation period"
        },
        {
          "abbreviation": "AST",
          "expansion": "aspartate aminotransferase"
        },
        {
          "abbreviation": "BMI",
          "expansion": "body mass index"
        },
        {
          "abbreviation": "C-I",
          "expansion": "check-in"
        },
        {
          "abbreviation": "CRU",
          "expansion": "clinical research unit"
        },
        {
          "abbreviation": "Cu",
          "expansion": "copper"
        },
        {
          "abbreviation": "D",
          "expansion": "day"
        },
        {
          "abbreviation": "ECG",
          "expansion": "electrocardiogram"
        },
        {
          "abbreviation": "EOS",
          "expansion": "End of Study"
        },
        {
          "abbreviation": "EOS/ET",
          "expansion": "End of Study or Early Termination"
        },
        {
          "abbreviation": "FDA",
          "expansion": "Food and Drug Administration"
        },
        {
          "abbreviation": "HIV",
          "expansion": "human immunodeficiency virus"
        },
        {
          "abbreviation": "HR",
          "expansion": "heart rate"
        },
        {
          "abbreviation": "I/O",
          "expansion": "input/output"
        },
        {
          "abbreviation": "IB",
          "expansion": "Investigator’s Brochure"
        },
        {
          "abbreviation": "IECs",
          "expansion": "Independent Ethics Committees"
        },
        {
          "abbreviation": "IRBs",
          "expansion": "Institutional Review Boards"
        },
        {
          "abbreviation": "LBC",
          "expansion": "labile bound copper"
        },
        {
          "abbreviation": "Mo",
          "expansion": "molybdenum"
        },
        {
          "abbreviation": "NCC",
          "expansion": "non-ceruloplasmin-bound copper"
        },
        {
          "abbreviation": "NCCcorrected",
          "expansion": "non-ceruloplasmin corrected copper concentrations corrected for TPC"
        },
        {
          "abbreviation": "OP",
          "expansion": "outpatient"
        },
        {
          "abbreviation": "PD",
          "expansion": "pharmacodynamic"
        },
        {
          "abbreviation": "PK",
          "expansion": "pharmacokinetic"
        },
        {
          "abbreviation": "PUF",
          "expansion": "plasma ultrafiltrate"
        },
        {
          "abbreviation": "PUF-Cu",
          "expansion": "plasma ultrafiltrate copper"
        },
        {
          "abbreviation": "PUF-Mo",
          "expansion": "plasma ultrafiltrate molybdenum"
        },
        {
          "abbreviation": "SAE",
          "expansion": "serious adverse event"
        },
        {
          "abbreviation": "SoA",
          "expansion": "Schedule of Activities"
        },
        {
          "abbreviation": "SS",
          "expansion": "steady state"
        },
        {
          "abbreviation": "TPC",
          "expansion": "tetrathiomolybdate- copper -albumin tripartite complex"
        },
        {
          "abbreviation": "UNS",
          "expansion": "unscheduled"
        },
        {
          "abbreviation": "WD",
          "expansion": "Wilson disease"
        }
      ]
    },
    "structure": {
      "document": {
        "title": "A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
        "version": "3.1 (US)",
        "versionDate": "18 Mar 2022"
      },
      "sections": [
        {
          "number": "1",
          "title": "PROTOCOL SUMMARY",
          "type": "Synopsis",
          "subsections": [
            {
              "number": "1.1",
              "title": "Synopsis"
            },
            {
              "number": "1.2",
              "title": "Schema"
            },
            {
              "number": "1.3",
              "title": "Schedule of Activities (SoA)"
            }
          ]
        },
        {
          "number": "2",
          "title": "INTRODUCTION",
          "type": "Introduction",
          "subsections": [
            {
              "number": "2.1",
              "title": "Study Rationale"
            },
            {
              "number": "2.2",
              "title": "Background"
            },
            {
              "number": "2.3",
              "title": "Benefit-Risk Assessment",
              "subsections": [
                {
                  "number": "2.3.1",
                  "title": "Risk Assessment"
                },
                {
                  "number": "2.3.1.1",
                  "title": "Coronavirus (SARS-CoV-2) Disease 2019"
                },
                {
                  "number": "2.3.2",
                  "title": "Benefit Assessment"
                },
                {
                  "number": "2.3.3",
                  "title": "Overall Benefit-Risk Conclusion"
                }
              ]
            }
          ]
        },
        {
          "number": "3",
          "title": "OBJECTIVES AND ENDPOINTS",
          "type": "Objectives"
        },
        {
          "number": "4",
          "title": "STUDY DESIGN",
          "type": "Study Design",
          "subsections": [
            {
              "number": "4.1",
              "title": "Overall Design"
            },
            {
              "number": "4.2",
              "title": "Scientific Rationale for Study Design"
            },
            {
              "number": "4.2.1",
              "title": "Participant Input into Design"
            },
            {
              "number": "4.3",
              "title": "Justification for Dose"
            },
            {
              "number": "4.4",
              "title": "End of Study Definition"
            }
          ]
        },
        {
          "number": "5",
          "title": "STUDY POPULATION",
          "type": "Study Population",
          "subsections": [
            {
              "number": "5.1",
              "title": "Inclusion Criteria"
            },
            {
              "number": "5.2",
              "title": "Exclusion Criteria"
            },
            {
              "number": "5.3",
              "title": "Lifestyle Considerations"
            },
            {
              "number": "5.4",
              "title": "Screen Failures"
            }
          ]
        },
        {
          "number": "6",
          "title": "STUDY INTERVENTION",
          "type": "Treatment"
        },
        {
          "number": "10.1.8",
          "title": "Study and Site Start and Closure",
          "type": "Other"
        },
        {
          "number": "10.1.9",
          "title": "Publication Policy",
          "type": "Other"
        },
        {
          "number": "10.2",
          "title": "Clinical Laboratory Tests",
          "type": "Assessments"
        },
        {
          "number": "10.3",
          "title": "Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting",
          "type": "Safety",
          "subsections": [
            {
              "number": "10.3.1",
              "title": "Definition of AE"
            },
            {
              "number": "10.3.2",
              "title": "Definition of SAE"
            },
            {
              "number": "10.3.3",
              "title": "Recording and Follow-Up of AE and/or SAE"
            },
            {
              "number": "10.3.4",
              "title": "Reporting of SAEs"
            }
          ]
        },
        {
          "number": "10.4",
          "title": "Contraceptive Guidance and Collection of Pregnancy Information",
          "type": "Ethics",
          "subsections": [
            {
              "number": "10.4.1",
              "title": "Definitions and Contraceptive Guidance"
            },
            {
              "number": "10.4.2",
              "title": "Collection of Pregnancy Information"
            }
          ]
        },
        {
          "number": "10.5",
          "title": "COVID-19 Vaccine Risk Assessment",
          "type": "Safety"
        },
        {
          "number": "10.6",
          "title": "Abbreviations",
          "type": "Other"
        },
        {
          "number": "10.7",
          "title": "Protocol Amendment History",
          "type": "Other"
        },
        {
          "number": "11",
          "title": "REFERENCES",
          "type": "References"
        }
      ]
    }
  }
}